Month: June 2022

In re Nektar Therapeutics: Ninth Circuit Affirms Dismissal of Securities Class Action Arising from Failure of Clinical Drug Trial  

Summary On May 19, 2022, a panel of the Ninth Circuit unanimously affirmed the district court’s dismissal of a putative securities fraud class action accusing Nektar Therapeutics and several of its executives of misleading investors about the results of a clinical drug trial. The court held that even if Nektar […]

Cooley Secures Complete Dismissal of Merger Class Action for Senomyx

Cooley secured a complete and significant victory for its clients, the former directors and officers of Senomyx, by obtaining a dismissal of a class action challenging the 2018 acquisition of the company by Swiss fragrance house Firmenich. The San Diego-based Cooley team was led by Peter Adams, Barrett Anderson and Dylan […]